Pinane-thromboxane A2 (PTA2, [1a,2P(Z),-3a(1 E,3R*),5a]-7-1343-hydroxy-1-octenyl6,6-dimethylbicyclo[3.l.l]hept-2-ylJ-5-heptenoic acid) has been synthesized and tested for biological activity in systems responsive to thromboxane A2, stable prostaglandin endoperoxide (PGH2) analogs, and prostacyclin (PGI2). At low concentrations, PTA2 inhibited cat coronary artery constriction induced by stable prostaglandin endoperoxide analogs, and it stabilized liver lysosomes. At slightly higher concentrations, it inhibited platelet aggregation.At still higher concentrations, PTA2 inhibited thromboxane synthetase, but it had no effect on prostacyclin synthetase. The analog also had no effect on the inhibition of platelet aggregation by PGI2 or prostaglandin D2. It is suggested that PTA2 has a suitable biochemical profile for use as an antithrombotic agent.In 1975, Hamberg et al. (1) proposed the structure (Fig. 1) for an unstable (half-life of about 30 s at pH 7.4 and 370C) substance with potent thrombotic and smooth muscle contracting properties that they named thromboxane A2 (TA2). The isolation or chemical synthesis of this important member of the arachidonic acid cascade (2) has not yet been achieved. Furthermore, no analogs of this structurally unusual molecule have been reported to date. We now wish to report the synthesis of a thromboxane A2 analog (structure 8a) and some of its interesting biological properties.
MATERIALS AND METHODSSynthesis of Pinane-Thromboxane A2, [la,2#(Z),3a-H(1 E,3R*),5aj -713 -(3-Hydroxy-l-octenyl-6,6 -dimethylbicyclo[3.1.1]hept-2-yll-5-heptenoic Acid. The thromboxane analog pinane-thromboxane A2 (PTA2, 8a) was synthesized from (-)-myrtenol (1) as outlined in Fig. 2 174.0, 139.6, 131.2, 130.2, 128.9, 73.0, 51.4, 48.8, 43.9, 41.7, 39.3, 38.6,37.4, 34.9, 34.3, 33.5, 32.4, 31.7, 28.2, 26.7, 25.2, 24.9, 23.0, 22.6, 14.0. Mass spectrum, parent ion massto-charge ratio 390. [aI122 +26.400 (methanol). Analysis, calculated for C25H4203: C 76.86% and H 10.87%; found: C 77.05% and H 11.08%. The 13C NMR spectra of 7a and 7b are of crucial value in assigning the stereochemistry of these compounds. In particular, the relatively low chemical shift for C-10 (PG numbering) in the 13C NMR spectra of 7a and 7b (533.3 ± 2 ppm) reveals the relative stereochemistry of the upper side chain by comparison to the corresponding model epimeric compounds from the myrtenol family, which exhibit this carbon at 3 33.2 ppm (C trans to the side chain) and 24.2 (C cis to the side chain) (4). PTA2 (8a)